Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Providing CLARITY: 3D Imaging of Biomarkers in Tumor Samples

Not Accessible

Your library or personal account may give you access

Abstract

The CLARITY method was used to transform core needle biopsies from patients with breast cancer, into optically transparent tissues, followed by multiplexed immunostaining and 3D imaging of key biomarkers. This data was compared to conventional FFPE thin-section methods. Manual pathology scoring of the 3D images from CLARITY processed samples demonstrated concordant results when compared to a set of 2D images scored throughout a similar sized FFPE block from the same patient.

© 2018 The Author(s)

PDF Article
More Like This
Biodynamic 3D Imaging for Personalized Cancer Care

David D. Nolte, Ran An, Michael Childress, and John Turek
ATh1O.6 CLEO: Applications and Technology (CLEO:A&T) 2014

Monitoring Breast Cancer Tumor Response At Different Timepoints During Pre-Surgical Chemotherapy with Diffuse Optical Spectroscopic Imaging

Albert E. Cerussi, Vaya W. Tanamai, Darren Roblyer, Shigeto Ueda, Amanda F. Durkin, Rita S. Mehta, David Hsiang, John Butler, and Bruce J. Tromberg
FME1 Frontiers in Optics (FiO) 2010

Biodynamic 4D Imaging of Living Cancer Biopsies for Personalized Selection of Chemotherapy

David D. Nolte, Zhe Li, Honggu Choi, John Turek, and Shadia Jalal
CTu4B.7 Clinical and Translational Biophotonics (Translational) 2018

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.